Durvalumab and Reclast

• Generic Name: durvalumab
• Dosage Forms: n.a.
• Other Brand Names: Imfinzi

Durvalumab is used to treat non-small cell lung cancer, and cancer of the bladder or urinary tract.

Durvalumab is sometimes given when the cancer has spread to other parts of the body or cannot be removed with surgery, or when other treatments did not work or have stopped working.

Durvalumab may also be used for purposes not listed in this medication guide.

• Generic Name: zoledronic acid
• Dosage Forms: injection, solution
• Other Brand Names: Reclast, Zometa, Aclasta, Zometa Concentrate

Reclast (zoledronic acid) (sometimes called zoledronate) is a bisphosphonate medicine that alters bone formation and breakdown in the body. This can slow bone loss and may help prevent bone fractures.

Reclast is used to treat or prevent osteoporosis caused by menopause, steroid use, or gonadal failure. This medicine is for use when you have a high risk of bone fracture due to osteoporosis.

Reclast is also used to increase bone mass in men who have osteoporosis, and to treat Paget's disease of bone in men and women.

Zometa is another brand of zoledronic acid used to treat high blood levels of calcium caused by cancer and multiple myeloma.

You should not use Reclast and Zometa at the same time.